"The current vaccines are not infection-blocking," Gates says, "They're not broad — so when new variants come up you lose protection — and they have very short duration, particularly in the people who matter, which are old people."1
COVID-19 shots' lack of efficacy and safety is not news, so why is this a remarkable statement coming from Gates? He's been a major proponent of mRNA technology and invested heavily in BioNTech, which developed the COVID-19 shot for Pfizer. He's since sold a lot of those shares, earning a 10x profit.
Gates Reaps Windfall Profits From mRNA Shot Investment
As reported by The Hill co-host Briahna Joy Gray, Gates invested $55 million in BioNtech in 2019, and it's now worth $550 million. He sold some of the stock at the end of 2022, when the share price was over $300 — representing a massive gain. Co-host Robby Soave then states:2
"Let's follow that trajectory: [Gates] invests heavily in BioNTech, 'mRNA vaccines are great, this is the future,' he talks about the vaccine timeline and how we can develop it faster, 'we might have to cut some corners on safety' … All in … sells it … makes a huge amount of money … but now it's 'yeah, it's okay, it could be better, but what we really need is this breath spray.'"